Inalgex

Etofenamate, the active ingredient in Inalgex, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a topical formulation for cutaneous use. It is employed to relieve pain and reduce inflammation in musculoskeletal conditions, particularly where localized therapy is preferred.

GNH USA supplies Inalgex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Customers benefit from reliable supply chains, batch traceability, and responsive technical support.

Etofenamate acts locally on inflammatory pathways in soft‑tissue and joint disorders. - Rheumatoid arthritis: reduces joint pain and swelling in affected areas. - Osteoarthritis: alleviates chronic discomfort and improves joint mobility. - Sprains and strains: provides localized pain relief and diminishes inflammation of injured muscles and ligaments.

Topical etofenamate may cause skin‑related reactions.

Common Side Effects: - Skin irritation: burning or stinging sensation at the application site. - Erythema: redness of the treated area. - Pruritus: itching or mild rash. - Dryness: localized skin dryness or peeling. - Contact dermatitis: mild allergic skin reaction.

Serious or Rare Side Effects: - Severe allergic reaction: angio‑edema or anaphylaxis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic NSAID effects: gastrointestinal ulceration, bleeding, or renal impairment. - Hepatotoxicity: abnormal liver function tests. - Severe skin necrosis: ulceration or necrotic lesions at the site.

When using Inalgex, consider the following safety measures. - Assess skin integrity: avoid application on broken, infected, or irritated skin. - Monitor for hypersensitivity: discontinue use if rash, swelling, or systemic allergic signs appear. - Cardiovascular caution: use with care in patients with known heart disease or hypertension. - Concomitant NSAIDs: avoid using other systemic NSAIDs to reduce gastrointestinal risk. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Etofenamate may interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Corticosteroids: elevated chance of ulceration or bleeding.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal clearance. - ACE inhibitors or ARBs: potential decline in renal function. - Lithium: NSAIDs may raise lithium serum levels, requiring monitoring.